alzheimer's semaglutide Associations of with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US - Wang - 2024 📢 BREAKING: New Alzheimer's Trial

In T2DM, agents such as semaglutide and tirzepatide effectively lower HbA1c levels, blood glucose levels, and body weight, outperforming conventional oral hypoglycemic agents and insulin

avoid drinking large volumes immediately with food, as this slows gastric emptying further

When providers have biomarker and genetic context from the Precision Peptide Genetic Test, they can better discuss individual tolerance expectations, monitoring frequency, and potential dosing adjustments for GLP-1 medications when combined with testosterone replacement

How to check whether your Blue Cross Blue Shield plan covers Zepbound What to do if insurance wont cover Zepbound How to save on Zepbound Zepbound (tirzepatide) is a once-weekly injectable GIP/glucagon-like peptide-1 (GLP-1) receptor agonist

Sources: National Institutes of Health (NIH) - Nutrition and Weight Management: American Diabetes Association (ADA) - Nutrition Recommendations: Tags Ready to Track Your GLP1 Journey

Tirzepatide, a medication that acts on both GLP-1 and GIP receptors, is FDA-approved for type 2 diabetes treatment and also used off-label for weight management